Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 102
of 6Next
1:

Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice.

Dunphy KA, Blackburn AC, Yan H, O'Connell LR, Jerry DJ.

Breast Cancer Res. 2008;10(3):R43. Epub 2008 May 12.

PMID: 18471300 [PubMed - indexed for MEDLINE]

2:

Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways.

Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ.

Oncogene. 2005 Sep 22;24(42):6345-53.

PMID: 15940247 [PubMed - indexed for MEDLINE]

3:

Hormone dependence in premalignant mammary progression.

Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J.

Cancer Res. 2003 Mar 1;63(5):1067-72.

PMID: 12615724 [PubMed - indexed for MEDLINE]

4:

Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.

Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ.

Cancer Res. 2004 Aug 1;64(15):5140-7.

PMID: 15289317 [PubMed - indexed for MEDLINE]

5:

Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.

Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D, Naber SP, Jerry DJ.

Am J Pathol. 2000 Dec;157(6):2151-9.

PMID: 11106587 [PubMed - indexed for MEDLINE]

6:

Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.

Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V, Koller BH.

Cancer Res. 2001 Sep 1;61(17):6577-82.

PMID: 11522657 [PubMed - indexed for MEDLINE]

7:

p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.

Vanzulli S, Efeyan A, Benavides F, Helguero LA, Peters G, Shen J, Conti CJ, Lanari C, Molinolo A.

Carcinogenesis. 2002 May;23(5):749-58.

PMID: 12016147 [PubMed - indexed for MEDLINE]

8:

Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.

Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D.

Breast Cancer Res. 2007;9(1):R12.

PMID: 17257424 [PubMed - indexed for MEDLINE]

9:

Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development.

Minter LM, Dickinson ES, Naber SP, Jerry DJ.

Development. 2002 Jun;129(12):2997-3008.

PMID: 12050146 [PubMed - indexed for MEDLINE]

10:

Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.

Loehberg CR, Thompson T, Kastan MB, Maclean KH, Edwards DG, Kittrell FS, Medina D, Conneely OM, O'Malley BW.

Cancer Res. 2007 Dec 15;67(24):12026-33.

PMID: 18089834 [PubMed - indexed for MEDLINE]

11:

p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.

Sivaraman L, Conneely OM, Medina D, O'Malley BW.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12379-84. Epub 2001 Oct 16.

PMID: 11606748 [PubMed - indexed for MEDLINE]

12:

Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.

Montero Girard G, Vanzulli SI, Cerliani JP, Bottino MC, Bolado J, Vela J, Becu-Villalobos D, Benavides F, Gutkind S, Patel V, Molinolo A, Lanari C.

Breast Cancer Res. 2007;9(2):R22.

PMID: 17341305 [PubMed - indexed for MEDLINE]

13:

Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.

Bustuoabad OD, di Gianni PD, Franco M, Kordon EC, Vanzulli SI, Meiss RP, Grion LC, Díaz GS, Nosetto SH, Hockl P, Lombardi MG, Pasqualini CD, Ruggiero RA.

Oncol Res. 2002;13(3):147-60.

PMID: 12549624 [PubMed - indexed for MEDLINE]

14:

Hormone-induced chromosomal instability in p53-null mammary epithelium.

Pati D, Haddad BR, Haegele A, Thompson H, Kittrell FS, Shepard A, Montagna C, Zhang N, Ge G, Otta SK, McCarthy M, Ullrich RL, Medina D.

Cancer Res. 2004 Aug 15;64(16):5608-16.

PMID: 15313898 [PubMed - indexed for MEDLINE]

16:

Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.

Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P.

Cancer Res. 2005 Apr 15;65(8):3493-6.

PMID: 15833886 [PubMed - indexed for MEDLINE]

17:

A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.

Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS, Medina D.

Oncogene. 2000 Feb 21;19(8):1052-8.

PMID: 10713689 [PubMed - indexed for MEDLINE]

18:

BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.

Blackburn AC, Brown JS, Naber SP, Otis CN, Wood JT, Jerry DJ.

Cancer Res. 2003 May 15;63(10):2364-8.

PMID: 12750252 [PubMed - indexed for MEDLINE]

19:

Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells.

Goepfert TM, McCarthy M, Kittrell FS, Stephens C, Ullrich RL, Brinkley BR, Medina D.

FASEB J. 2000 Nov;14(14):2221-9.

PMID: 11053243 [PubMed - indexed for MEDLINE]

20:

A mouse model for luminal epithelial like ER positive subtype of human breast cancer.

Kumar MJ, Ponvijay KS, Nandhini R, Nagarajan RS, Jose J, Srinivas G, Nagarajan P, Venkatesan R, Kumar K, Singh S.

BMC Cancer. 2007 Sep 20;7:180.

PMID: 17880731 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 102
of 6Next